The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.36.3.275

The diagnosis of atypical depression has been used in a variety of ways in the psychiatric literature. The authors review the different uses of the term and then examine the syndrome's capacity to reliably predict course of illness, family prevalence, biological test data, and response to treatment. They conclude that as a diagnosis, atypical depression is misleading and does not describe a discrete or homogeneous group of patients. However, the literature on atypical depression has been extremely important in identifying patients for whom pharmacological intervention may be of great benefit and for whom it has been underutilized in the past.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.